Changes in bone microarchitecture with abacavir--lamivudine versus tenofovir disoproxil fumarate--emtricitabine in adults living with HIV

AIDS. 2020 Sep 1;34(11):1687-1689. doi: 10.1097/QAD.0000000000002592.
No abstract available

Publication types

  • Research Support, U.S. Gov't, Non-P.H.S.

MeSH terms

  • Absorptiometry, Photon
  • Adult
  • Anti-HIV Agents / adverse effects*
  • Anti-HIV Agents / therapeutic use
  • Dideoxynucleosides / adverse effects
  • Drug Combinations
  • Emtricitabine / therapeutic use
  • Fractures, Bone / chemically induced*
  • HIV Infections / drug therapy*
  • Humans
  • Incidence
  • Lamivudine / adverse effects
  • Osteoporotic Fractures / chemically induced*
  • Osteoporotic Fractures / epidemiology
  • Tenofovir / adverse effects

Substances

  • Anti-HIV Agents
  • Dideoxynucleosides
  • Drug Combinations
  • abacavir, lamivudine drug combination
  • Lamivudine
  • Tenofovir
  • Emtricitabine
  • abacavir